Precision medicine and actionable alterations in lung cancer: A single institution experience.

ABSTRACT:

Objectives

Oncology has become more reliant on new testing methods and a greater use of electronic medical records, which provide a plethora of information available to physicians and researchers. However, to take advantage of vital clinical and research data for precision medicine, we must initially make an effort to create an infrastructure for the collection, storage, and utilization of this information with uniquely designed disease-specific registries that could support the collection of a large number of patients.

Materials and methods

In this study, we perform an in-depth analysis of a series of lung adenocarcinoma patients (n = 415) with genomic and clinical data in a recently created thoracic patient registry.

Results

Of the 415 patients with lung adenocarcin

SUBMITTER: Mambetsariev I 

PROVIDER: S-EPMC7012442 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature